EPISODE · Jul 24, 2023 · 9 MIN
Unlocking Precision Medicine: BullFrog AI's (Nasdaq: BFRG) Trailblazing Use of AI to Predict Therapeutic Success and Transform Drug Development
from Small Stocks, Big Money · host RedChip Companies
BullFrog AI (Nasdaq: BFRG) is a precision medicine company using AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development using its proprietary bfLEAP™ artificial intelligence platform. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics. Learn more at BFRGinfo.com. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. Bullfrog AI (Bullfrog) is a client of RedChip Companies, Inc. Bullfrog agreed to pay RedChip Companies, Inc. a $7,500 monthly cash fee, beginning upon closing of a minimum bridge financing of $500,000, and $50,000 of Rule 144 stock (based on IPO price) for six months of investor awareness services. Upon closing of Bullfrog’s IPO, the cash fee will increase to $15,000 monthly. For full disclosure, visit RedChip.com/disclosures.
What this episode covers
BullFrog AI (Nasdaq: BFRG) is a precision medicine company using AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development using its proprietary bfLEAP™ artificial intelligence platform. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics. Learn more at BFRGinfo.com. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. Bullfrog AI (Bullfrog) is a client of RedChip Companies, Inc. Bullfrog agreed to pay RedChip Companies, Inc. a $7,500 monthly cash fee, beginning upon closing of a minimum bridge financing of $500,000, and $50,000 of Rule 144 stock (based on IPO price) for six months of investor awareness services. Upon closing of Bullfrog’s IPO, the cash fee will increase to $15,000 monthly. For full disclosure, visit RedChip.com/disclosures.
NOW PLAYING
Unlocking Precision Medicine: BullFrog AI's (Nasdaq: BFRG) Trailblazing Use of AI to Predict Therapeutic Success and Transform Drug Development
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.